China's XIO Group acquires Lumenis for $510m
Chinese investment fund XIO Group is acquiring Lumenis Ltd. (Nasdaq: LMNS), which develops surgical, ophthalmology and aesthetic applications, for $14 per share in cash, for an aggregate purchase price of $510 million. This is a 16% premium on the Yokneam based company's closing price on Nasdaq yesterday and 20% above its IPO price in early 2014.
Lumenis CEO Tzipi Ozer-Armon said, "This acquisition is a strong recognition and vote of confidence in Lumenis' achievements and its employees, and I am excited about the future prospects of Lumenis. Over the past 3 years we have managed to transform Lumenis into a strong, growing and profitable company. We have refocused our strategy, introduced new products, and tripled our EBITDA. Furthermore, we have created a very bright and promising future for Lumenis by building a robust pipeline of innovative products, a strong sales team in each region, and by enhancing our global brand recognition. I am confident that we will continue to thrive and reach new heights together with XIO Group."
Israeli Actor Aviv Alush To Play Jesus
Glenn Drew: Our students attend Harvard and Princeton on quite a regular basis
Interview with CEO of the American Hebrew Academy
Igor Kolomoisky: I told Yatsenyuk he was putting himself at risk
On relations with the president, his administration and Prime Minister Arseny Yatsenyuk
New High-Tech Collar Tracks The Health Of Your Pets
The PetPace collar uses non-invasive sensors to monitor data